Episode Details
Back to Episodes
Navigating GDPR in the Pharmaceutical Sector
Description
How do pharmaceutical companies navigate GDPR, HIPAA, and a rapidly evolving regulatory landscape?
In this conversation, Punit and Timothy explore how organizations manage the balance between innovation and compliance, especially when working with sensitive health and patient data.
You’ll learn why companies see regulation in different ways: as a challenge, a responsibility, and increasingly, a business enabler. The key lies in focusing on the core principles behind the laws, especially reducing the risk of re-identifying individuals while still extracting value from data.
They also dive into one of the most complex areas of clinical trials. With global data, multiple regulations, and long timelines, companies must find practical ways to stay compliant while accelerating research. From using privacy-enhancing technologies to building look-alike models and managing consent effectively, new approaches are helping organizations move forward.
👉 Listen to the full episode to understand how pharmaceutical companies can turn compliance into a strategic advantage while protecting patient privacy.
RESOURCES
Websites www.fit4privacy.com,www.punitbhatia.com, https://www.linkedin.com/company/integralprivacytechnologies/posts/?feedView=all ,
https://www.linkedin.com/in/timothynobles/ , https://timothyn.medium.com/ , https://growskills.store/
Podcast https://www.fit4privacy.com/podcast
Blog https://www.fit4privacy.com/blog
YouTube http://youtube.com/fit4privacy
Insights https://growskills.store/insights/
ISO Standard Courses at https://growskills.store/courses